Katarzyna Kuter

2.6k total citations · 1 hit paper
41 papers, 1.8k citations indexed

About

Katarzyna Kuter is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Katarzyna Kuter has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cellular and Molecular Neuroscience, 23 papers in Neurology and 12 papers in Molecular Biology. Recurrent topics in Katarzyna Kuter's work include Parkinson's Disease Mechanisms and Treatments (21 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neurological disorders and treatments (8 papers). Katarzyna Kuter is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (21 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neurological disorders and treatments (8 papers). Katarzyna Kuter collaborates with scholars based in Poland, Germany and United States. Katarzyna Kuter's co-authors include Agnieszka M. Jurga, Krystyna Ossowska, Jadwiga Wardas, Urszula Głowacka, Przemysław Nowak, Maria Śmiałowska, Barbara A. Zieba, M. Angela Cenci, Jolanta Konieczny and Wacław Kolasiewicz and has published in prestigious journals such as PLoS ONE, Brain Research and International Journal of Molecular Sciences.

In The Last Decade

Katarzyna Kuter

41 papers receiving 1.8k citations

Hit Papers

Overview of General and D... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katarzyna Kuter Poland 20 646 625 569 527 267 41 1.8k
Graça Baltazar Portugal 22 391 0.6× 501 0.8× 523 0.9× 343 0.7× 232 0.9× 55 1.6k
Janelle Drouin‐Ouellet Canada 21 473 0.7× 849 1.4× 974 1.7× 634 1.2× 351 1.3× 39 2.0k
Fen Wang China 29 406 0.6× 395 0.6× 756 1.3× 376 0.7× 449 1.7× 94 2.2k
Qian Jiang China 29 456 0.7× 842 1.3× 1.4k 2.5× 495 0.9× 335 1.3× 73 2.6k
Daniel Alvarez‐Fischer Germany 24 1.1k 1.6× 989 1.6× 904 1.6× 1.3k 2.5× 478 1.8× 44 3.1k
Xibin Liang United States 19 479 0.7× 418 0.7× 530 0.9× 239 0.5× 407 1.5× 23 1.7k
Valerie Joers United States 18 571 0.9× 590 0.9× 657 1.2× 811 1.5× 322 1.2× 27 1.9k
Salvatore Caniglia Italy 27 496 0.8× 909 1.5× 987 1.7× 560 1.1× 242 0.9× 39 2.3k
Wenjie Xie China 23 399 0.6× 723 1.2× 687 1.2× 822 1.6× 329 1.2× 55 2.1k
Jannette Rodrı́guez-Pallares Spain 23 417 0.6× 809 1.3× 768 1.3× 426 0.8× 216 0.8× 49 1.8k

Countries citing papers authored by Katarzyna Kuter

Since Specialization
Citations

This map shows the geographic impact of Katarzyna Kuter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarzyna Kuter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarzyna Kuter more than expected).

Fields of papers citing papers by Katarzyna Kuter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarzyna Kuter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarzyna Kuter. The network helps show where Katarzyna Kuter may publish in the future.

Co-authorship network of co-authors of Katarzyna Kuter

This figure shows the co-authorship network connecting the top 25 collaborators of Katarzyna Kuter. A scholar is included among the top collaborators of Katarzyna Kuter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarzyna Kuter. Katarzyna Kuter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wardas, Jadwiga, et al.. (2023). GABA-A Alpha 2/3 but Not Alpha 1 Receptor Subunit Ligand Inhibits Harmaline and Pimozide-Induced Tremor in Rats. Biomolecules. 13(2). 197–197. 5 indexed citations
4.
Kuter, Katarzyna, Maria Śmiałowska, & Krystyna Ossowska. (2021). The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system. Pharmacological Reports. 74(1). 67–83. 7 indexed citations
5.
Jurga, Agnieszka M., et al.. (2020). Overview of General and Discriminating Markers of Differential Microglia Phenotypes. Frontiers in Cellular Neuroscience. 14. 198–198. 649 indexed citations breakdown →
6.
Szewczyk, Bernadeta, et al.. (2017). Antidepressant activity of zinc: Further evidence for the involvement of the serotonergic system. Pharmacological Reports. 69(3). 456–461. 9 indexed citations
7.
Kuter, Katarzyna, et al.. (2017). Fluoride Alteration of [3H]Glucose Uptake in Wistar Rat Brain and Peripheral Tissues. Neurotoxicity Research. 31(3). 436–443. 15 indexed citations
8.
Kuter, Katarzyna, et al.. (2016). Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(4). 741–753. 41 indexed citations
9.
Kuter, Katarzyna, et al.. (2012). Neonatal DSP-4 Treatment Modifies Antinociceptive Effects of the CB1 Receptor Agonist Methanandamide in Adult Rats. Neurotoxicity Research. 23(1). 39–48. 6 indexed citations
10.
11.
Ossowska, Krystyna, et al.. (2011). Alteration of GSK-3β in the hippocampus and other brain structures after chronic paraquat administration in rats.. PubMed. 49(4). 319–27. 8 indexed citations
12.
Strosznajder, Joanna B., et al.. (2010). Glycogen Synthase Kinase 3β and Its Phosphorylated Form (Y216) in the Paraquat-Induced Model of Parkinsonism. Neurotoxicity Research. 19(1). 162–171. 13 indexed citations
13.
Wernicke, Catrin, Barbara A. Zieba, Katarzyna Kuter, et al.. (2010). 9-Methyl-β-carboline has restorative effects in an animal model of Parkinson’s disease. Pharmacological Reports. 62(1). 35–53. 43 indexed citations
14.
Wardas, Jadwiga, et al.. (2009). Evaluation of a new model of Parkinson's disease employing chronic intraventricular infusion of MPP+ with Alzet osmotic minipumps to rats. Pharmacological Reports. 61(2). 365–366. 1 indexed citations
15.
Kuter, Katarzyna, Maria Śmiałowska, Joanna M. Wierońska, et al.. (2007). Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Brain Research. 1155. 196–207. 63 indexed citations
16.
Lorenc‐Koci, Elżbieta, Hans Rommelspacher, G. Schulze, et al.. (2006). Parkinson??s disease-like syndrome in rats induced by 2,9-dimethyl-??-carbolinium ion, a ??-carboline occurring in the human brain. Behavioural Pharmacology. 17(5-6). 463–473. 13 indexed citations
17.
Rommelspacher, Hans, Krystyna Ossowska, G. Schulze, et al.. (2006). S19 ENDOGENOUS TOXINS IN PARKINSON??S DISEASE. Behavioural Pharmacology. 17(5-6). 540–540. 1 indexed citations
18.
Ossowska, Krystyna, Maria Śmiałowska, Katarzyna Kuter, et al.. (2006). Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: Implications for Parkinson’s disease. Neuroscience. 141(4). 2155–2165. 60 indexed citations
19.
Ossowska, Krystyna, Jadwiga Wardas, Maria Śmiałowska, et al.. (2005). A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long‐term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?. European Journal of Neuroscience. 22(6). 1294–1304. 103 indexed citations
20.
Konradi, Christine, Jenny E. Westin, Manolo Carta, et al.. (2004). Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia. Neurobiology of Disease. 17(2). 219–236. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026